Sandra C Paek, MD
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Paek’s office at (408) 972-6931 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A95182 · Current
Licensed to practise in California · since 2006 · expires 2027-12-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$822
Pharmacies billed $822 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
60 generic and 0 brand-name prescriptions · $822 in drug cost · 38 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 29 | $324 | $11 |
Year by year
| 2024 | 60 | 47 | None | 0% | $822 |
| 2023 | 58 | 48 | 19% (11) | 0% | $756 |
| 2022 | 61 | 47 | 20% (12) | 0% | $904 |
| 2021 | 59 | 50 | None | None | $810 |
| 2020 | 47 | 39 | None | None | $841 |
| 2019 | 49 | 42 | 29% (14) | 0% | $689 |
| 2018 | 80 | 71 | 31% (25) | None | $1,520 |
| 2017 | 126 | 94 | 49% (62) | 0% | $2,763 |
| 2016 | 109 | 83 | 44% (48) | None | $1,933 |
| 2015 | 83 | 64 | 36% (30) | None | $2,008 |
| 2014 | 99 | 73 | 21% (21) | None | $62,966 |
| 2013 | 61 | 46 | None | None | $2,071 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Cephalexin | 27 | $306 | $11 |
2022: 2 drugs
| Cephalexin | 24 | $270 | $11 |
| Hydrocodone-Acetaminophen | 12 | $99 | $8 |
2021: 1 drug
| Cephalexin | 30 | $352 | $12 |
2020: 1 drug
| Cephalexin | 16 | $148 | $9 |
2019: 2 drugs
| Cephalexin | 14 | $113 | $8 |
| Hydrocodone-Acetaminophen | 14 | $97 | $7 |
2018: 2 drugs
| Cephalexin | 27 | $257 | $10 |
| Hydrocodone-Acetaminophen | 23 | $172 | $7 |
2017: 2 drugs
| Hydrocodone-Acetaminophen | 60 | $636 | $11 |
| Cephalexin | 46 | $452 | $10 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 43 | $776 | $18 |
| Cephalexin | 40 | $429 | $11 |
2015: 2 drugs
| Hydrocodone-Acetaminophen | 25 | $451 | $18 |
| Cephalexin | 34 | $354 | $10 |
2014: 2 drugs
| Cephalexin | 37 | $405 | $11 |
| Hydrocodone-Acetaminophen | 17 | $166 | $10 |
2013: 1 drug
| Cephalexin | 24 | $255 | $11 |
Money from drug and device companies
$129 in 2025
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Rhapsido | $67 | 1 payment
|
| Pfizer | Cibinqo | $62 | 1 payment
|
See all 2 published payments
| Novartis Pharmaceuticals | Meals · 2025-10-24 | Rhapsido | $67 |
| Pfizer | Meals · 2025-10-23 | Cibinqo | $62 |
Professional record
- NPI
- 1679651160
- Licence
- CA A95182California A95182: Current · expires 2027-12-31
- Trained
- Washington University School of Medicine, 2000
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ND0101X (207ND0101X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-11-01
- NPI last updated
- 2021-12-20
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.